Search research articles

Related Concept Videos

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PvDBP gene amplification is associated with functional immune evasion by Plasmodium vivax in vivo.

Research square·2026

Same author

Comprehensive characterization of <i>Plasmodium vivax</i> antigens using a high-density peptide array.

bioRxiv : the preprint server for biology·2026

Same author

A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice.

Nature microbiology·2025

Same author

CD44 cross-linking promotes Plasmodium falciparum invasion.

Nature communications·2025

Same author

<i>Plasmodium falciparum</i> exploits NUAK1 to establish infection in human erythrocytes.

bioRxiv : the preprint server for biology·2025

Same author

Covalent Irreversible Inhibitors of Tetracycline Destructases.

ACS infectious diseases·2025

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Nov 5, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Protein-based antigen presentation platforms for nanoparticle vaccines.

Brian Nguyen¹, Niraj H Tolia²

¹Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA.

|May 14, 2021

Summary

Next-generation vaccines utilize nanoparticle platforms to enhance immunogenicity. This approach improves antigen presentation, leading to more effective vaccines against global diseases like COVID-19.

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Related Experiment Videos

Last Updated: Nov 5, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Area of Science:

Vaccinology
Nanotechnology
Immunology

Background:

Modern vaccines often use minimal antigen approaches, improving safety but potentially reducing efficacy due to poor immunogenicity.
There is a critical need for advanced vaccines against global health challenges such as COVID-19, malaria, and AIDS.

Purpose of the Study:

To explore nanoparticle platforms as a strategy for enhancing vaccine immunogenicity.
To review natural platforms, antigen attachment methods, and self-assembly techniques for engineered vaccine delivery systems.

Main Methods:

Summarizing natural nanoparticle platforms.
Investigating various methods for attaching antigens to nanoparticle surfaces.
Examining advancements in self-assembling nanoparticle systems.

Main Results:

Nanoparticle platforms enhance antigen presentation, leading to improved uptake by antigen-presenting cells.
These platforms facilitate lymph node trafficking and boost B-cell activation via increased avidity and particle size.
The study reviews design considerations for effective engineered nanoparticle vaccines.

Conclusions:

Nanoparticle vaccine platforms offer a promising strategy to overcome the limitations of traditional vaccine designs.
Further research into critical parameters will guide the development of more potent and effective next-generation vaccines.